NVP-ACC789

CAS: 300842-64-2

Ref. 3D-AMA84264

Produktinformation

• Name: NVP-ACC789
• Marke: Biosynth
• Beschreibung: NVP-ACC789 is a protein kinase inhibitor that inhibits the activity of the vascular endothelial growth factor receptor (VEGFR). It has been shown to be effective against cancer-related genes and tumor cells in animal models. The drug is also being monitored for adverse effects in humans. The drug can be administered orally or intravenously. NVP-ACC789 has an effective dose of 100 mg per day and can be used as a single agent or combined with other drugs such as nitrosourea.

Chemische Eigenschaften

• Molekulargewicht: 405.29 g/mol
• Formel: C₂₁H₁₇BrN₄
• Reinheit: Min. 95%